 This label requires evidence of a disease flare accompanying the headache, and resolution of the headache with immunosuppressant treatment.However, a meta-analysis found no correlation between headaches and disease activity.Critics of this concept argue that there are no quality studies showing that headaches in patients with SLE differ from those in the general population.